Combination of Castle Biosciences’ DecisionDx-UM and PRAME show predicting outcomes in patients with uveal melanoma: Study: Friendswood, Texas Friday, December 19, 2025, 15:00 H ...

FRIENDSWOOD, Texas, Dec. 17, 2025 (GLOBE NEWSWIRE) -- (Nasdaq: CSTL), a company improving health through innovative tests ...

York-based biotech firm Aptamer Group has announced a licensing agreement with synthetic biology and genomics company Twist ...

The Vietnam Academy of Science and Technology (VAST) organized a ceremony in Hanoi on December 11 to announce DNA ...

CAGR is driven by advancements in epigenetics research, methylation analysis technologies, and the rising need for ...

A landmark study, titled “How error correction affects polymerase chain reaction deduplication: A survey based on unique molecular identifier datasets of short reads” recently published in ...

Saga PLC - Kent, England-based provider of products and services for people over 50 - Announces that its 20-year motor and home insurance partnership with Ageas UK, wholly-owned subsidiary of Ageas SA ...

Nucleix, a liquid biopsy company revolutionizing cancer treatment by detecting the disease earlier, today announced that European Urology Oncology published results of a clinical study demonstrating ...

Global Nanopore Sequencing Market OverviewThe nanopore sequencing market is projected to grow at a CAGR of around 11% during the forecast period, driven by rising demand for real-time, portable DNA ...

Early ctDNA clearance, combined with complete response on PET-CT, correlates with prolonged progression-free survival. ctDNA testing is minimally invasive and can be conducted repeatedly, offering a ...

Agreement brings Pixelgen Proxiome Kit to South Korea as demand for protein interactome's tools growsSTOCKHOLM, Dec. 15, 2025 /PRNewswire/ -- Pixelgen ...

Q3 2025 Earnings Call Transcript December 12, 2025 Operator: BillionToOne Third Quarter 2025 Earnings Call. [Operator Instructions]. Please be advised that today’s call is being recorded. I would now ...